From tsunyoto at itg.be  Thu May 17 09:23:37 2018
From: tsunyoto at itg.be (Temmy Sunyoto)
Date: Thu, 17 May 2018 12:23:37 +0000
Subject: [Leish-l] Need your help: a 5 minutes survey on barriers to
 effective supply of LEISHMANIASIS medicine
Message-ID: <HE1PR05MB1819A505FED14A3DB1154068B8910@HE1PR05MB1819.eurprd05.prod.outlook.com>

Dear admin of the group,
Please help my research by allowing me to post this request below.
Many thanks,



Dear subscribers,

My name is Temmy, and currently I am a Marie-Curie PhD candidate with the project on Access to Care of Leishmaniasis in Africa with Prof dr Marleen Boelaert. As part of this project, we are conducting a study focusing on supply and pharmaceutical barriers on the medicines for neglected tropical disease (NTD), especially to leishmaniasis. As it is not amenable to preventive chemotherapy through mass drug administration, diagnosis and treatment is crucial. However, available drugs are old, toxic, too expensive or come from single producer. Shortages have been reported in the past, and new medicines are sorely needed. Our country focus is in Ethiopia, Kenya, Somalia, South Sudan, Sudan and Uganda .

This survey aims to explore the perceived barriers towards effective supply of medicines for leishmaniasis, which albeit included in some National Essential Drug List, are not registered in the countries and imported through NGOs or others. Therefore, we invite everyone who is interested in this topic to take 5 minute to complete the survey by clicking the link below:


If you currently live/work in the countries above, here is the survey for you (COUNTRY PERSPECTIVE)
https://www.surveymonkey.com/r/36VNFDN
If you are doing/have done procurement for any of the countries above, or who are/had been working in procurement or supply agencies, here is the survey for you (PROCURER )
https://www.surveymonkey.com/r/59JR3LK

Your response will be anonymized and by doing this you are providing valuable input towards advocacy in securing access to medicines of a life threatening disease of kala-azar. Please also kindly let me know should you be willing to speak more about the issue in an in-depth interview (by phone or Skype).

Your help is highly appreciated and many thanks in advance,

Temmy Sunyoto, MD MPH
Unit of Epidemiology and Control of Tropical Diseases
Institute of Tropical Medicine, Antwerp
www.itg.be<http://www.itg.be>
www.euroleish.net<http://www.euroleish.net>

Tel: +32 (0)3 345 56 49
Mobile: +32 (0)487 72 60 48
Skype: temmy.sunyoto


From directordcbd at gmail.com  Wed May 23 03:39:29 2018
From: directordcbd at gmail.com (Prof. Dr. Moazzem Hossain)
Date: Wed, 23 May 2018 12:39:29 +0600
Subject: [Leish-l] Need your help: a 5 minutes survey on barriers to
 effective supply of LEISHMANIASIS medicine
In-Reply-To: <HE1PR05MB1819A505FED14A3DB1154068B8910@HE1PR05MB1819.eurprd05.prod.outlook.com>
References: <HE1PR05MB1819A505FED14A3DB1154068B8910@HE1PR05MB1819.eurprd05.prod.outlook.com>
Message-ID: <CAE-TCmTJDRG2itvL-WYMz2cySGL0RY-hGiUjKS7USeZHb-R66g@mail.gmail.com>

Temmy Sunyoto, MD MPH
Thank you for your email. I have retired from Government service from the
post of   Director Disease control, Ministry of Health, Bangladesh. Now I
am attached with my own Filaria and Thalassaemia Hospital and Institute for
Neglected diseases.
Please keep record my other email <moazzem.iacib at gmail.com>.
If you need the questionaire to fill , please inform me.

Best wishes
Professor Dr. Moazzem Hossain


On Thu, May 17, 2018 at 6:23 PM, Temmy Sunyoto <tsunyoto at itg.be> wrote:

> Dear admin of the group,
> Please help my research by allowing me to post this request below.
> Many thanks,
>
>
>
> Dear subscribers,
>
> My name is Temmy, and currently I am a Marie-Curie PhD candidate with the
> project on Access to Care of Leishmaniasis in Africa with Prof dr Marleen
> Boelaert. As part of this project, we are conducting a study focusing on
> supply and pharmaceutical barriers on the medicines for neglected tropical
> disease (NTD), especially to leishmaniasis. As it is not amenable to
> preventive chemotherapy through mass drug administration, diagnosis and
> treatment is crucial. However, available drugs are old, toxic, too
> expensive or come from single producer. Shortages have been reported in the
> past, and new medicines are sorely needed. Our country focus is in
> Ethiopia, Kenya, Somalia, South Sudan, Sudan and Uganda .
>
> This survey aims to explore the perceived barriers towards effective
> supply of medicines for leishmaniasis, which albeit included in some
> National Essential Drug List, are not registered in the countries and
> imported through NGOs or others. Therefore, we invite everyone who is
> interested in this topic to take 5 minute to complete the survey by
> clicking the link below:
>
>
> If you currently live/work in the countries above, here is the survey for
> you (COUNTRY PERSPECTIVE)
> https://www.surveymonkey.com/r/36VNFDN
> If you are doing/have done procurement for any of the countries above, or
> who are/had been working in procurement or supply agencies, here is the
> survey for you (PROCURER )
> https://www.surveymonkey.com/r/59JR3LK
>
> Your response will be anonymized and by doing this you are providing
> valuable input towards advocacy in securing access to medicines of a life
> threatening disease of kala-azar. Please also kindly let me know should you
> be willing to speak more about the issue in an in-depth interview (by phone
> or Skype).
>
> Your help is highly appreciated and many thanks in advance,
>
> Temmy Sunyoto, MD MPH
> Unit of Epidemiology and Control of Tropical Diseases
> Institute of Tropical Medicine, Antwerp
> www.itg.be<http://www.itg.be>
> www.euroleish.net<http://www.euroleish.net>
>
> Tel: +32 (0)3 345 56 49
> Mobile: +32 (0)487 72 60 48
> Skype: temmy.sunyoto
>
> _______________________________________________
> Leish-l mailing list
> Leish-l at lineu.icb.usp.br
> http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l
>
> --
> This email was sent by icb.usp.br
>



-- 
Prof. Dr. Moazzem Hossain)
Chairman
Institute of Allergy and Clinical Immunology of Bangladesh (IACIB)
Director
Filaria and General Hospital.
Thalassaemia Hospital and Institute
2, Zinzira Hospital Road, Birulia Union,
PO: Dairy Farm, Upozila: Savar,
Dhaka- 1341, Bangladesh.
(Ex- Director Disease Control,
Ministry of Health, Bangladesh)
Phone: 880-1715038551 (Mobile)
            Website <www.iacib.org>

From regina.dasilva at hotmail.com  Wed May 23 12:41:08 2018
From: regina.dasilva at hotmail.com (=?utf-8?B?UkVHSU5BIEPDiUxJQSBTSUxWQQ==?=)
Date: Wed, 23 May 2018 15:41:08 +0000
Subject: [Leish-l] =?utf-8?q?=5BLeish-I=5D_Permissible_values_=E2=80=8B?=
 =?utf-8?q?=E2=80=8Bof_colorimetric_PCR_for_visceral_leishmaniasis_in_the_?=
 =?utf-8?q?acute_phase?=
In-Reply-To: <mailman.1.1527087601.27814.leish-l@lineu.icb.usp.br>
References: <mailman.1.1527087601.27814.leish-l@lineu.icb.usp.br>
Message-ID: <MWHPR19MB13575BF601C3FFB083A0C6E1936B0@MWHPR19MB1357.namprd19.prod.outlook.com>

Dear admin of the group,
Please help my research by allowing me to post this request below.
Many thanks,


I AM FINISHING A MASTER'S DISSERTATION ON COLORIMETRIC PCR IN THE ACUTE PHASE (INFLAMMATION) OF VISCERAL LEISMANIOSIS. I DID THE PCR IN LABORATORY IN BUT I AM NOT KNOWING TO INTERPRET THE RESULTS. I WOULD LIKE HELP IN THE MEANING OF MEASURING WHICH VALUES I USE AS PARAMETER OF THE PCR IN THE ACUTE PHASE. DOES IT STAY HIGH OR LOW? WHEN IS LOW BECAUSE THE DECREASE OCCURS?




Regina C?lia da Silva

Farmac?utica e Economista

Laborat?rio de Pesquisas em Leishmanioses - UFPI

Mobile: +5586999024068

________________________________
De: leish-l-bounces em lineu.icb.usp.br <leish-l-bounces em lineu.icb.usp.br> em nome de leish-l-request em lineu.icb.usp.br <leish-l-request em lineu.icb.usp.br>
Enviado: quarta-feira, 23 de maio de 2018 12:00
Para: leish-l em lineu.icb.usp.br
Assunto: Leish-l Digest, Vol 115, Issue 1

Send Leish-l mailing list submissions to
        leish-l em lineu.icb.usp.br

To subscribe or unsubscribe via the World Wide Web, visit
        http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l
or, via email, send a message with subject or body 'help' to
        leish-l-request em lineu.icb.usp.br

You can reach the person managing the list at
        leish-l-owner em lineu.icb.usp.br

When replying, please edit your Subject line so it is more specific
than "Re: Contents of Leish-l digest..."


Today's Topics:

   1. Need your help: a 5 minutes survey on barriers to effective
      supply of LEISHMANIASIS medicine (Temmy Sunyoto)


----------------------------------------------------------------------

Message: 1
Date: Thu, 17 May 2018 12:23:37 +0000
From: Temmy Sunyoto <tsunyoto em itg.be>
Subject: [Leish-l] Need your help: a 5 minutes survey on barriers to
        effective supply of LEISHMANIASIS medicine
To: "leish-l em lineu.icb.usp.br" <leish-l em lineu.icb.usp.br>
Message-ID:
        <HE1PR05MB1819A505FED14A3DB1154068B8910 em HE1PR05MB1819.eurprd05.prod.outlook.com>

Content-Type: text/plain; charset="us-ascii"

Dear admin of the group,
Please help my research by allowing me to post this request below.
Many thanks,



Dear subscribers,

My name is Temmy, and currently I am a Marie-Curie PhD candidate with the project on Access to Care of Leishmaniasis in Africa with Prof dr Marleen Boelaert. As part of this project, we are conducting a study focusing on supply and pharmaceutical barriers on the medicines for neglected tropical disease (NTD), especially to leishmaniasis. As it is not amenable to preventive chemotherapy through mass drug administration, diagnosis and treatment is crucial. However, available drugs are old, toxic, too expensive or come from single producer. Shortages have been reported in the past, and new medicines are sorely needed. Our country focus is in Ethiopia, Kenya, Somalia, South Sudan, Sudan and Uganda .

This survey aims to explore the perceived barriers towards effective supply of medicines for leishmaniasis, which albeit included in some National Essential Drug List, are not registered in the countries and imported through NGOs or others. Therefore, we invite everyone who is interested in this topic to take 5 minute to complete the survey by clicking the link below:


If you currently live/work in the countries above, here is the survey for you (COUNTRY PERSPECTIVE)
https://www.surveymonkey.com/r/36VNFDN
If you are doing/have done procurement for any of the countries above, or who are/had been working in procurement or supply agencies, here is the survey for you (PROCURER )
https://www.surveymonkey.com/r/59JR3LK

Your response will be anonymized and by doing this you are providing valuable input towards advocacy in securing access to medicines of a life threatening disease of kala-azar. Please also kindly let me know should you be willing to speak more about the issue in an in-depth interview (by phone or Skype).

Your help is highly appreciated and many thanks in advance,

Temmy Sunyoto, MD MPH
Unit of Epidemiology and Control of Tropical Diseases
Institute of Tropical Medicine, Antwerp
www.itg.be<http://www.itg.be>
www.euroleish.net<http://www.euroleish.net>

Tel: +32 (0)3 345 56 49
Mobile: +32 (0)487 72 60 48
Skype: temmy.sunyoto



------------------------------

_______________________________________________
Leish-l mailing list
Leish-l em lineu.icb.usp.br
http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l


End of Leish-l Digest, Vol 115, Issue 1
***************************************

--
This email was sent by icb.usp.br